BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $386 | -27.2% | 10,225 | -12.2% | 0.00% | -33.3% |
| Q2 2023 | $530 | -42.9% | 11,641 | -49.2% | 0.00% | -40.0% |
| Q1 2023 | $929 | -95.4% | 22,899 | -94.2% | 0.01% | -95.1% |
| Q4 2022 | $20,163 | -99.9% | 395,580 | -38.2% | 0.10% | -43.0% |
| Q3 2022 | $34,462,000 | -17.8% | 639,835 | -2.0% | 0.18% | -8.7% |
| Q2 2022 | $41,923,000 | -22.6% | 652,704 | -6.6% | 0.20% | -1.5% |
| Q1 2022 | $54,162,000 | -40.1% | 698,510 | -33.7% | 0.20% | -36.2% |
| Q4 2021 | $90,446,000 | -31.4% | 1,053,659 | -35.7% | 0.31% | -36.5% |
| Q3 2021 | $131,777,000 | -28.2% | 1,638,405 | -28.2% | 0.49% | -27.0% |
| Q2 2021 | $183,645,000 | -6.6% | 2,281,296 | -2.2% | 0.67% | -18.9% |
| Q1 2021 | $196,687,000 | -3.6% | 2,332,071 | -8.3% | 0.83% | -7.7% |
| Q4 2020 | $204,089,000 | +6.7% | 2,543,474 | +6.9% | 0.90% | -5.5% |
| Q3 2020 | $191,324,000 | +72.6% | 2,379,062 | +84.7% | 0.95% | +60.9% |
| Q2 2020 | $110,875,000 | +10.9% | 1,287,755 | +4.5% | 0.59% | -2.6% |
| Q1 2020 | $100,004,000 | +652.9% | 1,231,728 | +675.4% | 0.61% | +806.0% |
| Q4 2019 | $13,283,000 | +61.4% | 158,852 | +68.9% | 0.07% | +59.5% |
| Q3 2019 | $8,228,000 | -7.6% | 94,065 | -14.0% | 0.04% | -16.0% |
| Q2 2019 | $8,906,000 | +2.2% | 109,374 | +2.1% | 0.05% | +2.0% |
| Q1 2019 | $8,711,000 | +19.8% | 107,130 | -3.0% | 0.05% | +4.3% |
| Q4 2018 | $7,272,000 | -73.2% | 110,490 | -71.5% | 0.05% | -84.3% |
| Q2 2015 | $27,093,000 | -4.8% | 387,431 | -6.8% | 0.30% | -0.3% |
| Q1 2015 | $28,464,000 | -5.9% | 415,531 | +0.7% | 0.30% | -12.3% |
| Q4 2014 | $30,242,000 | -2.2% | 412,631 | -4.2% | 0.34% | +5.9% |
| Q3 2014 | $30,914,000 | -10.2% | 430,731 | -9.5% | 0.32% | -5.0% |
| Q2 2014 | $34,417,000 | -53.1% | 476,031 | -52.3% | 0.34% | -56.1% |
| Q1 2014 | $73,368,000 | -69.8% | 997,120 | -71.4% | 0.77% | -70.9% |
| Q4 2013 | $242,905,000 | +5.8% | 3,492,520 | -0.1% | 2.66% | +2.7% |
| Q3 2013 | $229,647,000 | -7.5% | 3,495,920 | -2.4% | 2.59% | -4.2% |
| Q2 2013 | $248,154,000 | – | 3,582,420 | – | 2.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |